Variables | Coef | SE | t-value | p-value | [95% Conf Interval] | Sig | ||
---|---|---|---|---|---|---|---|---|
Therapeutic area | Oncologic | 0.39 | 0.424 | − 0.87 | 0.386 | 0.046 | 3.286 | |
Outcomes classification | Survival | 3.134 | 3.381 | 1.06 | 0.29 | 0.378 | 25.961 | |
Therapeutic alternatives | No | 0.823 | 0.58 | − 0.28 | 0.782 | 0.206 | 3.279 | |
Rarity of disease | Ultra-rare | 0.822 | 0.685 | − 0.24 | .814 | 0.16 | 4.209 | |
Safety | No PASS | 0.055 | 0.068 | − 2.34 | 0.02 | 0.005 | 0.627 | ** |
Type of population | Paediatric | 0.422 | 0.358 | − 1.02 | 0.31 | 0.08 | 2.227 | |
TPR conclusion | Positive | 225.762 | 304.687 | 4.02 | 0 | 16.028 | 3180.004 | *** |
Conditional approval | No | 9.07 | 8.729 | 2.29 | 0.022 | 1.375 | 59.818 | ** |
Constant | 0.087 | 0.112 | − 1.89 | 0.058 | 0.007 | 1.088 | * | |
Mean dependent var | 0.655 | SD dependent var | 0.478 | |||||
Pseudo r-squared | 0.472 | Number of obs | 87 | |||||
Chi-square | 52.947 | Prob > chi2 | 0.000 | |||||
Akaike crit. (AIC) | 77.141 | Bayesian crit. (BIC) | 99.335 |